Background
==========

Ventriculitis is a serious complication of external ventricular drainage (EVD). Silver-processed catheters (S-PC) are available that are intended to reduce the risk of infection. Clinical results of use of S-PC in other settings have been mixed, with benefit limited to only short-term use \[[@B1],[@B2]\]. Little clinical experience of S-PC for EVD use \[[@B3]\], and no in-depth laboratory studies have been reported. We therefore examined the catheters to determine their antimicrobial activity in clinically relevant tests.

Materials and methods
=====================

Test bacteria were *Staphylococcus epidermidis*, *Staphylococcus aureus*(MRSA) and *Escherichia coli*. Catheters (Silverline^®^) were purchased from Forth Medical Ltd, UK. For comparison, an in-house processed catheter \[[@B4]\] was tested. Both contain nanoparticulate silver. Two tests were conducted, and scanning electron microscopy (SEM) was also carried out. tK100: This measures the time taken to kill 100% of bacteria when attached to the catheter material \[[@B5]\]. *In vitro*challenge5 determines the ability of the S-PC to resist colonisation in flow conditions when repeatedly challenged with bacteria (as in EVD). In addition, focused ion beam SEM (FIBSEM) investigated the distribution of silver in the catheter materials.

Results
=======

At high bacterial inoculum (107 cfu/mL) both S-PCs failed to show any antimicrobial activity and they were also not able to resist colonisation. At low inoculum (104 cfu/mL) initial reduction in viability in the tK100 test was followed by resurgence after 2 days to control levels. Again, the S-PC became colonised. FIBSEM showed more silver nanoparticles in the in-house catheter material but it still did not show superior activity.

Conclusion
==========

S-PC exhibit antimicrobial activity for a few days, after which they are ineffective in killing attached bacteria. This may be sufficient to reduce infection rates in very short-term EVD.
